The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zornetta, Irene ^a   Azarnia Tehran, Domenico ^a   Arrigoni, Giorgio ^a   Anniballi, Fabrizio ^b   Bano, Luca ^c   Leka, Oneda ^a   Zanotti, Giuseppe ^a   Binz, Thomas ^d   Montecucco, Cesare ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; METALLOPROTEINASE; NEUROTOXIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; BACTERIAL GENOME; CELL MEMBRANE; CHEMISTRY; CLOSTRIDIUM BOTULINUM; GENETICS; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN DOMAIN; PROTEIN FOLDING; WEISSELLA;

AMINO ACID SEQUENCE; BOTULINUM TOXINS; CELL MEMBRANE; CLOSTRIDIUM BOTULINUM; GENOME, BACTERIAL; METALLOPROTEASES; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; NEUROTOXINS; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN FOLDING; WEISSELLA;

EID: 84979268226     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30257     Document Type: Article

References (36)

1. Johnson, E. A., Montecucco, C. Botulism. Handb Clin Neurol 91, 333-368 (2008).
2. Hill, K. K., Smith, T. J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol 364, 1-20 (2013).
3. Centers for Disease Control and Prevention, D. o. H. a. H. S. Vol. 77 61083-61115 (Fed. Regist., 2012).
4. Pantano, S., Montecucco, C. The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell Mol Life Sci. 71, 793-811 (2014).
5. Südhof, T. C., Rizo, J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol. 3 (2011).
6. Rossetto, O., Pirazzini, M., Montecucco, C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 12 (2014).
7. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., Stevens, R. C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 5, 898-902 (1998).
8. Swaminathan, S., Eswaramoorthy, S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol. 7, 693-699 (2000).
9. Montal, M. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem 79, 591-617 (2010).
10. Binz, T., Sikorra, S., Mahrhold, S. Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering. Toxins (Basel) 2, 665-682 (2010).
11. Pirazzini, M. et al. On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments. Biochim Biophys Acta. 1858, 467-474 (2016).
12. Rummel, A. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364, 61-90 (2013).
13. Dressler, D. Clinical applications of botulinum toxin. Curr Opin Microbiol 15, 325-336 (2012).
14. Hallett, M. et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 67, 94-114 (2013).
15. Comella, C. L., Pullman, S. L. Botulinum toxins in neurological disease. Muscle Nerve 29, 628-644 (2004).
16. Eleopra, R., Tugnoli, V., Quatrale, R., Rossetto, O., Montecucco, C. Different types of botulinum toxin in humans. Mov Disord 19 Suppl 8, S53-S59 (2004).
17. Masuyer, G., Chaddock, J. A., Foster, K. A., Acharya, K. R. Engineered botulinum neurotoxins as new therapeutics. Annu Rev Pharmacol Toxicol 54, 27-51 (2014).
18. Tanizawa, Y. et al. Draft Genome Sequence of Weissella oryzae SG25T, Isolated from Fermented Rice Grains. Genome Announc 2 (2014).
19. Costa, F. A., Leal, C. A., Schuenker, N. D., Leite, R. C., Figueiredo, H. C. Characterization of Weissella ceti infections in Brazilian rainbow trout, Oncorhynchus mykiss (Walbaum), farms and development of an oil-adjuvanted vaccine. J Fish Dis. 38, 295-302 (2015).
20. Fairfax, M. R., Lephart, P. R., Salimnia, H. Weissella confusa: problems with identification of an opportunistic pathogen that has been found in fermented foods and proposed as a probiotic. Front Microbiol 5, 254, doi: 10.3389/fmicb.2014.00254 (2014).
21. Fusco, V. et al. The genus Weissella: taxonomy, ecology and biotechnological potential. Front Microbiol 6, 155 (2015).
22. Mansfield, M. J., Adams, J. B., Doxey, A. C. Botulinum neurotoxin homologs in non-Clostridium species. FEBS Lett. 589, 342-348 (2015).
23. Chai, Q. et al. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444, 1096-1100 (2006).
24. Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845-854 (2013).
25. Tonello, F., Montecucco, C. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol Aspects Med. 30, 431-438 (2009).
26. Binz, T., Bade, S., Rummel, A., Kollewe, A., Alves, J. Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization. Biochemistry 41, 1717-1723 (2002).
27. Rigoni, M., Caccin, P., Johnson, E. A., Montecucco, C., Rossetto, O. Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A. Biochem Biophys Res Commun 288, 1231-1237 (2001).
28. Maslanka, S. E. et al. A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin. J Infect Dis. 213, 379-385 (2016).
29. Schiavo, G., Montecucco, C. Tetanus and botulism neurotoxins: isolation and assay. Methods Enzymol 248, 643-652 (1995).
30. Bowen, M., Brunger, A. T. Conformation of the synaptobrevin transmembrane domain. Proc Natl Acad Sci USA 103, 8378-8383 (2006).
31. Lindau, M., Hall, B. A., Chetwynd, A., Beckstein, O., Sansom, M. S. Coarse-grain simulations reveal movement of the synaptobrevin C-terminus in response to piconewton forces. Biophys J. 103, 959-969 (2012).
32. Fang, Q., Zhao, Y., Lindau, M. Juxtamembrane tryptophans of synaptobrevin 2 control the process of membrane fusion. FEBS Lett. 587, 67-72 (2013).
33. Al-Abdul-Wahid, M. S., Demill, C. M., Serwin, M. B., Prosser, R. S., Stewart, B. A. Effect of juxtamembrane tryptophans on the immersion depth of Synaptobrevin, an integral vesicle membrane protein. Biochim Biophys Acta 1818, 2994-2999 (2012).
34. Sweeney, S. T., Broadie, K., Keane, J., Niemann, H., O'Kane, C. J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron 14, 341-351 (1995).
35. Rossi, V. et al. Longins and their longin domains: regulated SNAREs and multifunctional SNARE regulators. Trends Biochem Sci. 29, 682-688 (2004).
36. Lee, K. et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog 9, e1003690 (2013).